Lena Beckers, MD, analyzed real-world outcomes of AcrySof® IQ Vivity® IOL implantation in patients with mild retinal comorbidities. Results showed good visual acuity, high spectacle independence, and strong patient satisfaction, with minimal visual disturbances. Findings support the IOL as a viable option for appropriately selected patients.
Up Next:
Mini-Monovision Outcomes Compared to Emmetropia Target with an Extended Depth of Focus IOL
J. Nigel Kirkpatrick, MD, FRCOphth
Wavefront-Shaping Presbyopia Correction Toric IOL: Visual Performance and Patient Satisfaction
Sathish Srinivasan, FRCSEd, FRCOphth, FACS,
Final Results Of Clinical Performance of the Extended Range of Vision Intraocular Lens in Patients with Previous Corneal Laser Refractive Surgery
Humberto Carreras Diaz, MD
